Altered antioxidant enzyme activity with severity and comorbidities of chronic obstructive pulmonary disease (COPD) in South Indian population
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2054-9040
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Altered antioxidant enzyme activity with severity and comorbidities of chronic obstructive pulmonary disease (COPD) in South Indian population ; volume:3 ; number:1 ; day:30 ; month:3 ; year:2017 ; pages:1-11 ; date:12.2017
COPD - research and practice ; 3, Heft 1 (30.3.2017), 1-11, 12.2017
- Keyword
-
Atemwegskrankheit
Atemnot
- Creator
-
Mohammed, Asimuddin
- Contributor
-
Gutta, Vijayalakshmi
Ansari, Mohd Soheb
Saladi Venkata, Rajagopal
Jamil, Kaiser
SpringerLink (Online service)
- DOI
-
10.1186/s40749-017-0023-z
- URN
-
urn:nbn:de:1111-201704178202
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
- 15.08.2025, 7:33 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Mohammed, Asimuddin
- Gutta, Vijayalakshmi
- Ansari, Mohd Soheb
- Saladi Venkata, Rajagopal
- Jamil, Kaiser
- SpringerLink (Online service)
Other Objects (12)
Altered fibroblast proteoglycan production in COPD
Obstructive sleep apnea and comorbidities: a dangerous liaison
Comorbidities and COPD severity in a clinic-based cohort
Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study
Long term management of obstructive sleep apnea and its comorbidities
Identifying neurological comorbidities in obstructive sleep apnea patients through polysomnography
Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
Functional predictors discriminating Asthma–COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD)
Impact of comorbidities in COPD clinical control criteria. The CLAVE study
Biomarkers for comorbidities modulate the activity of T-xells in COPD
Altered effector function of peripheral cytotoxic cells in COPD
Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
Altered fibroblast proteoglycan production in COPD
Obstructive sleep apnea and comorbidities: a dangerous liaison
Comorbidities and COPD severity in a clinic-based cohort
Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study
Long term management of obstructive sleep apnea and its comorbidities
Identifying neurological comorbidities in obstructive sleep apnea patients through polysomnography
Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
Functional predictors discriminating Asthma–COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD)
Impact of comorbidities in COPD clinical control criteria. The CLAVE study
Biomarkers for comorbidities modulate the activity of T-xells in COPD
Altered effector function of peripheral cytotoxic cells in COPD
Real-world retrospective cohort study ARCTIC shows burden of comorbidities in Swedish COPD versus non-COPD patients
Altered fibroblast proteoglycan production in COPD
Obstructive sleep apnea and comorbidities: a dangerous liaison
Comorbidities and COPD severity in a clinic-based cohort
Comorbidities Associated with Obstructive Sleep Apnea: a Retrospective Study
Long term management of obstructive sleep apnea and its comorbidities
Identifying neurological comorbidities in obstructive sleep apnea patients through polysomnography
Pulmonary artery stiffness in chronic obstructive pulmonary disease (copd) - the mesa copd study
Functional predictors discriminating Asthma–COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD)
Impact of comorbidities in COPD clinical control criteria. The CLAVE study
Biomarkers for comorbidities modulate the activity of T-xells in COPD
Altered effector function of peripheral cytotoxic cells in COPD